ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (Q64992343)
Jump to navigation
Jump to search
scientific article published on 6 November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. |
scientific article published on 6 November 2017 |
Statements
ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (English)
1 reference
Andreas von Deimling
1 reference
Guido Reifenberger
1 reference
David Capper
1 reference
Jörg Felsberg
1 reference
Ghazaleh Tabatabai
1 reference
Daniel Schrimpf
1 reference
Stefan M Pfister
1 reference
David Jones
1 reference
Michael Weller
1 reference
Ulrich Roelcke
1 reference
Andreas Hottinger
1 reference
Francisca Joerger
1 reference
Andrea Schmid
1 reference
Ludwig Plasswilm
1 reference
Christoph Mancao
1 reference
Katrin Conen
1 reference
Thomas Hundsberger
1 reference
Francesca Caparrotti
1 reference
Roger von Moos
1 reference
Christian Riklin
1 reference
Patrick Roth
1 reference
Elisabeth Jane Rushing
1 reference
Lauren Abrey
1 reference
Leonhard Held
1 reference
Adrian Ochsenbein
1 reference
Hans-Georg Wirsching
1 reference
6 November 2017
1 reference
19
1 reference
Suppl 6
1 reference
vi2-vi2
1 reference